Home > Healthcare > Medical Devices > Diagnostic Devices > HIV Diagnostics Market

HIV Diagnostics Market Share

Report ID: GMI491
Published Date: Apr 2022
Report Format: PDF

Download Free Sample

HIV Diagnostics Market Share

Some of the notable industry players operating in the HIV diagnostics industry include

Chembio Diagnostics
OraSure Technologies
Abbott Laboratories
Becton Dickinson and company
Cepheid
Omega Diagnostics
BIONEER CORPORATION
Roche Diagnostics
Biomerieux
Qiagen

These market players are adopting numerous growth strategies such as collaboration, acquisition & merger, partnership and product launches to sustain market competition in HIV diagnostics market.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

HIV diagnostics market value exceeded USD 690 million in 2021 and is expected to grow at a CAGR of 0.8% over 2022-2028, driven by the surging disease burden of HIV infections in developing nations.

The market size from diagnostics laboratories is anticipated to expand at a CAGR of 0.8% from 2022 to 2028 driven by continuous technological advancements in laboratory devices.

HIV diagnostic industry share from viral load test type was over USD 450 million during 2021 and will expand as these tests help to enhance the quality and outcome of treatment for infected people.

Africa HIV diagnostics market share accounted for 38% of the overall industry revenue in 2021 and will exhibit consistent growth due to the increasing awareness initiatives by private and government players.